(CAS No. 861205-83-6) Tesofencin Citrate

Tesofencin citrate for use

Tesofe nsine Citrate is a serotonin reuptake inhibitor originally developed to treat Parkinson's disease and Alzheimer's disease. Tesofencin helps obese patients lose weight and lose weight from the right parts of their body and the right components (fat), according to a report by researchers at the 16th European Conference on Obesity.

Danish researchers studied the effects of Tesofencin treatment on body composition, including body weight, fat mass, waist circumference, and sagittal diameter. The study was a randomized, double-blind, placebo-controlled b clinical trial involving 203 obese men and women with a body mass index of 30-40 and no other medical conditions. After a 2-week dietary and physical activity induction period, they were assigned to drug therapy for 24 weeks, receiving doses of 0.25 mg, 0.5 mg, 1.0 mg of terexofencin daily or a corresponding placebo. The results show that Tesofencin is very effective against central obesity. Another study showed that low doses of tesofencin were safe and effective in treating obesity.